文献速递重症综合管理与镇静镇痛心脑血管急症复苏、休克与脓毒症

院外心脏骤停患者目标温度管理后反弹高热的关联因素:Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors 试验的探索性亚

Factors Associated With Rebound Hyperthermia After Targeted Temperature Management in Out-of-Hospital Cardiac Arrest Patients: An Explorative Substudy of the Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors Trial.
PubMed 文献 · Crit Care Explor · 2021-07-06
一句话结论约1/3的目标温度管理患者出现反弹高热,且与功能预后不良独立相关(OR 0.42),年轻男性、炎症反应重及使用机械胸外按压者更易发生。

该研究为 Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors 试验的事后分析,纳入10个欧洲ICU共338例院外心脏骤停后接受33°C目标温度管理48或24小时的患者。反弹高热定义为目标温度管理及复温后最高体温超过38.5°C,发生率为30%(103/338)。多因素分析显示,年龄增长(OR 0.97)和72小时内严重急性肾损伤(OR 0.35)与反弹高热减少相关;男性(OR 3.94)、最高C反应蛋白值(OR 1.04)及心肺复苏中使用机械胸外按压(OR 2.00)与反弹高热增多相关。反弹高热与6个月良好功能预后(CPC 1-2)的OR为0.42(95%CI 0.22-0.79)。

要点

  • 反弹高热定义为目标温度管理及复温后最高体温>38.5°C,338例中103例(30%)发生。
  • 反弹高热与6个月良好功能预后(CPC 1-2)降低独立相关(OR 0.42;95%CI 0.22-0.79)。
  • 良好预后组复温后体温>38.5°C、>39°C、>39.5°C的时间比例均显著低于预后不良组(2.5% vs 6.3%;0.14% vs 2.7%;0.03% vs 0.71%)。
  • 预后不良组反弹高热发生时间更晚(中位33.2小时 vs 6.5小时,P<0.01)。
  • 男性(OR 3.94)、最高CRP值(OR 1.04)、机械胸外按压(OR 2.00)与反弹高热增多相关;年龄增长(OR 0.97)和严重急性肾损伤(OR 0.35)与减少相关。

适用人群与场景

  • 纳入 Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors 试验中在10个欧洲ICU接受33°C目标温度管理48或24小时的院外心脏骤停患者,共338例。

诊断标准与关键阈值

  • 反弹高热定义:目标温度管理及复温后最高体温超过38.5°C。
  • 良好功能预后定义:6个月时脑功能分类(CPC)1或2。
  • 严重急性肾损伤定义:ICU入科72小时内发生严重急性肾损伤(原文未给出具体分期标准)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 反弹高热(目标温度管理及复温后体温>38.5°C)与6个月良好功能预后降低独立相关(OR 0.42;95%CI 0.22-0.79),需关注并处理。
  • 预后不良组反弹高热发生时间更晚(中位33.2小时 vs 6.5小时),复温后长时间体温>38.5°C、>39°C、>39.5°C的比例更高。

研究设计与关键结果

  • 研究类型:Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors 试验的事后分析;样本量338例,10个欧洲ICU。
  • 干预与对照:无干预,所有患者接受33°C目标温度管理48或24小时。
  • 主要结果:反弹高热发生率30%(103/338);反弹高热与良好功能预后降低相关(OR 0.42;95%CI 0.22-0.79)。
  • 多因素分析:年龄增长(OR 0.97;95%CI 0.95-0.99;P=0.02)和严重急性肾损伤(OR 0.35;95%CI 0.13-0.91;P=0.03)与反弹高热减少相关;男性(OR 3.94;95%CI 1.34-11.57;P=0.01)、最高CRP值(OR 1.04;95%CI 1.01-1.07;P=0.02)及机械胸外按压(OR 2.00;95%CI 1.10-3.67;P=0.02)与反弹高热增多相关。
  • 次要结果:良好预后组复温后体温>38.5°C时间比例2.5% vs 6.3%(P=0.03),>39°C为0.14% vs 2.7%(P<0.01),>39.5°C为0.03% vs 0.71%(P<0.01);反弹高热中位时间预后不良组33.2小时(IQR 14.3-53.0)vs 6.5小时(IQR 2.2-34.1),P<0.01。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后探索性亚组分析(post hoc analysis)。
  • 局限:事后分析、探索性设计,原文未提及证据等级或推荐强度;样本量338例,10个中心。

对床旁实践的改变

  • 对于院外心脏骤停后接受33°C目标温度管理的患者,应关注复温后反弹高热(>38.5°C),尤其是年轻男性、炎症反应重(最高CRP值高)及心肺复苏中使用机械胸外按压者。
  • 反弹高热发生时间较晚(预后不良组中位33.2小时)且与不良功能预后相关,提示复温后需持续监测体温,但原文未提供具体监测频率或处理方案。

指南或共识出处

  • Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors 试验(原文未提供完整指南或共识名称及年份)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: To investigate rebound hyperthermia following targeted temperature management after cardiac arrest and its impact on functional outcome.

DESIGN: Post hoc analysis.

SETTING: Ten European ICUs.

PATIENTS: Patients included in the time-differentiated therapeutic hypothermia in out-of-hospital cardiac arrest survivors trial treated with targeted temperature management at 33°C for 48 or 24 hours. Favorable functional outcome was defined as a Cerebral Performance Category of 1 or 2 at 6 months.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of 338 included patients, 103 (30%) experienced rebound hyperthermia defined as a maximum temperature after targeted temperature management and rewarming exceeding 38.5°C. Using multivariate logistic regression analysis, increasing age (odds ratio, 0.97; 95% CI, 0.95-0.99; p = 0.02) and severe acute kidney injury within 72 hours of ICU admission (odds ratio, 0.35; 95% CI, 0.13-0.91; p = 0.03) were associated with less rebound hyperthermia, whereas male gender (odds ratio, 3.94; 95% CI, 1.34-11.57; p = 0.01), highest C-reactive protein value (odds ratio, 1.04; 95% CI, 1.01-1.07; p = 0.02), and use of mechanical chest compression during cardiopulmonary resuscitation (odds ratio, 2.00; 95% CI, 1.10-3.67; p = 0.02) were associated with more rebound hyperthermia. Patients with favorable functional outcome spent less time after rewarming over 38.5°C (2.5% vs 6.3%; p = 0.03), 39°C (0.14% vs 2.7%; p < 0.01), and 39.5°C (0.03% vs 0.71%; p < 0.01) when compared with others. Median time to rebound hyperthermia was longer in the unfavorable functional outcome group (33.2 hr; interquartile range, 14.3-53.0 hr vs 6.5 hr; interquartile range, 2.2-34.1; p < 0.01). In a predefined multivariate binary logistic regression model, rebound hyperthermia was associated with decreased odds of favorable functional outcome (odds ratio, 0.42; 95% CI, 0.22-0.79).

CONCLUSIONS: One-third of targeted temperature management patients experience rebound hyperthermia, and it is more common in younger male patients with an aggravated inflammatory response and those treated with a mechanical chest compression device. Later onset of rebound hyperthermia and temperatures exceeding 38.5°C associate with unfavorable outcome.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Holm A, Kirkegaard H, Taccone FS, et al. Factors Associated With Rebound Hyperthermia After Targeted Temperature Management in Out-of-Hospital Cardiac Arrest Patients: An Explorative Substudy of the Time-Differentiated Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Survivors Trial. Crit Care Explor. 2021. PMID: 34250498. doi:10.1097/CCE.0000000000000458

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。